Artiva Biotherapeutics (ARTV) Ending Cash Balance (2023 - 2026)
Artiva Biotherapeutics (ARTV) recorded Ending Cash Balance of $301.92 million in Q2 2026, up 943.6% from $28.93 million a year earlier.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Ending Cash Balance (2023 - 2026) Analysis & Trends
For FY2025, Artiva Biotherapeutics reported Ending Cash Balance of $27.16 million, down 32.9% from FY2024.
- Across earlier years, Ending Cash Balance came in at $40.49 million in FY2024 (-24.7%) and $53.76 million in FY2023.
- The Q2 2026 figure is the highest quarterly Ending Cash Balance in data going back to Q2 2023.
- On a year-over-year basis, Ending Cash Balance rose in 1 of the last eight quarters, with growth averaging 91.8%.
- Peak year-over-year performance for Ending Cash Balance in the last five years was growth of 943.6% in Q2 2026, against a decline of 53.7% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $21.42 million (Q1 2026), $27.16 million (Q4 2025) and $25.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Artiva Biotherapeutics | 200.70 Mn | -118.40 Mn | - | 61.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 61.74 Mn |
| Jun 30, 2026 | 301.92 Mn |
| Mar 31, 2026 | 21.42 Mn |
| Dec 31, 2025 | 27.16 Mn |
| Sep 30, 2025 | 25.97 Mn |
| Jun 30, 2025 | 28.93 Mn |
| Mar 31, 2025 | 30.86 Mn |
| Dec 31, 2024 | 40.49 Mn |
| Sep 30, 2024 | 56.14 Mn |
| Jun 30, 2024 | 34.51 Mn |
| Mar 31, 2024 | 48.46 Mn |
| Dec 31, 2023 | 53.76 Mn |
| Sep 30, 2023 | 66.14 Mn |
| Jun 30, 2023 | 53.95 Mn |
API Access
Artiva Biotherapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();